1. [ANMCO/GISE/SICCH Inter-Society Consensus Document: Antithrombotic therapy after surgery or structural interventional procedures for valvular heart diseases: how to treat postoperative complications]
- Author
-
Leonardo, Patanè, Andrea, Di Lenarda, Nadia, Aspromonte, Innocenzo, Bianca, Piera, Capranzano, Marco, Di Eusanio, Stefania, Di Fusco, Giuseppe, Di Tano, Domenico, Gabrielli, Andrea, Garatti, Giovanna, Geraci, Piersilvio, Gerometta, Antonio, Miceli, Andrea, Montalto, Francesco, Musumeci, Giuseppe, Musumeci, Federico, Nardi, Alessandro, Parolari, Paolo Giuseppe, Pino, Antonino Salvatore, Rubino, Carlo, Savini, Giovanni, Troise, Giuseppe, Tarantini, Stefano, Urbinati, Ferdinando, Varbella, and Michele Massimo, Gulizia
- Subjects
Heart Valve Prosthesis Implantation ,Consensus ,Postoperative Complications ,Fibrinolytic Agents ,Pregnancy ,Thromboembolism ,Practice Guidelines as Topic ,Pregnancy Complications, Cardiovascular ,Heart Valve Diseases ,Anticoagulants ,Humans ,Female - Abstract
Continuous improvement of technologies, devices and drugs needs a renewal and update of current recommendations and guidelines on antithrombotic strategies, especially in those fields where literature lacks of established scientific evidences. Accordingly, the aim of this consensus statement is to provide support for antithrombotic therapy based on current guidelines and the most recent scientific evidences.After an overview on the currently available devices, the appropriate therapy according to type of procedure and implanted device is discussed. The occurrence of postoperative thromboembolic and/or hemorrhagic complications is analyzed, along with the appropriate diagnostic tools and therapeutic approach. A section is dedicated to counseling to pregnancy in women with heart valve prosthesis. Finally, the role of novel oral anticoagulants is discussed, and indications are provided for the management of patients undergoing surgery or interventional procedures on oral anticoagulation therapy.
- Published
- 2019